u/fasting_insulin_f

Retitled — the original quoted an obesity endpoint as a glycaemic one.

Identifying details redacted from the exported report above.

A1c, CGM, or fingersticks — which are we discussing?

Cosigning the wiki point, and also: ask anyway. The wiki cannot tell you it understood your question.

Assumed the peptide purity conversations transferred and they do not. Different analytical problem entirely.

Daily rather than weekly sounds trivial until you think about what a missed dose means in each case.

Disagreeing with this bit: daily dosing is a different adherence problem, not a better one.

Correction: that is the oral peptide product, which is a different thing entirely. This one is a small molecule.

the pharmacist is often the fastest route to a definite answer

Confused a rejected claim with a denied authorization for a month and pursued entirely the wrong process.

The three separate questions people ask here as though they were one.

Is it approved for sale — a national regulatory question with one answer. Is it covered — a provincial or private-plan question with many answers. Can I actually get this quantity dispensed — a quantity-limit question that is separate from coverage and stops as many people.

Say which of the three you are asking and name your province and plan type. Threads that do this get answered in two replies; threads that do not generate a page of people talking past each other, all of them correct about somewhere else.

Identifying details redacted from the exported report above.

Identifying details redacted from the exported report above.

postprandial excursions are where most of the improvement shows up first

How to ask a question here so that you get a useful answer.

Say what week you are in, whether you are using a pen or a vial, what country you are in, and what you have already read. Those four facts turn a question that gets three contradictory answers into one that gets a specific one.

And do ask. The basic questions get searched for constantly, so a clear answer here helps a stream of people who will never post. The only genuinely unwelcome thing on this board is being unpleasant to somebody for not knowing something yet.

formulary decisions are provincial, so the province is the first fact

Agreed — week two with nothing on the scale is so common it should be in the sidebar. It probably is.

say the province or the answers will be wrong

Reconstructed six weeks from memory once and later found receipts that contradicted my own log. Never again.

Left up. It distinguishes the sensor data from the lab result, which most posts here do not.

Employer-sponsored plans have their own criteria and appeal processes, independent of the provincial formulary.

Adding the fastest step — ask the pharmacist. They can usually check in minutes.

Daily dosing gives a very different exposure profile from a weekly injectable: peaks and troughs within each day rather than a smoothed weekly curve.

Disagreeing with this bit: daily dosing is a different adherence problem, not a better one.

Went looking for independent testing on this and found essentially nothing, which was clarifying.

My A1c moved and it turned out to have nothing to do with glucose at all.

employer plans have their own criteria and their own appeals

Missing entries recorded as blanks preserve the shape of the series. Dropping them silently makes the remaining points look more regular than they were.

Oral semaglutide is a peptide co-formulated with an absorption enhancer and carries food and water timing requirements. A small molecule does not have that constraint, which is the practical distinction.

I confused two very similar words on my first order and asked here, expecting to be mocked. Three people explained it properly instead.